[Interferon in the treatment of recurrent laryngeal papillomas].
The authors present their first experiences in the treatment of recurrent laryngeal papillomas with human leukocyte Interferon (HLI). Because of the impossibility of avoiding recurrences, the results were not satisfactory in most of the cases. The schedule for therapy has not yet been determined definitely.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007822:Laryngeal Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D010212:Papilloma / Q000628:therapy*
D007370:Interferon Type I
Interferon in der Behandlung rezidivierender Larynxpapillome.